BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 29794082)

  • 1. Deletion of Macrophage Low-Density Lipoprotein Receptor-Related Protein 1 (LRP1) Accelerates Atherosclerosis Regression and Increases C-C Chemokine Receptor Type 7 (CCR7) Expression in Plaque Macrophages.
    Mueller PA; Zhu L; Tavori H; Huynh K; Giunzioni I; Stafford JM; Linton MF; Fazio S
    Circulation; 2018 Oct; 138(17):1850-1863. PubMed ID: 29794082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of Macrophage Low-Density Lipoprotein Receptor-Related Protein 1 Confers Resistance to the Antiatherogenic Effects of Tumor Necrosis Factor-α Inhibition.
    Zhu L; Giunzioni I; Tavori H; Covarrubias R; Ding L; Zhang Y; Ormseth M; Major AS; Stafford JM; Linton MF; Fazio S
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1483-95. PubMed ID: 27365402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-density lipoprotein receptor-related protein 1 prevents early atherosclerosis by limiting lesional apoptosis and inflammatory Ly-6Chigh monocytosis: evidence that the effects are not apolipoprotein E dependent.
    Yancey PG; Ding Y; Fan D; Blakemore JL; Zhang Y; Ding L; Zhang J; Linton MF; Fazio S
    Circulation; 2011 Jul; 124(4):454-64. PubMed ID: 21730304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficiency of Dab2 (Disabled Homolog 2) in Myeloid Cells Exacerbates Inflammation in Liver and Atherosclerotic Plaques in LDLR (Low-Density Lipoprotein Receptor)-Null Mice-Brief Report.
    Adamson SE; Polanowska-Grabowska R; Marqueen K; Griffiths R; Angdisen J; Breevoort SR; Schulman IG; Leitinger N
    Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1020-1029. PubMed ID: 29599136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage LRP1 (Low-Density Lipoprotein Receptor-Related Protein 1) Is Required for the Effect of CD47 Blockade on Efferocytosis and Atherogenesis-Brief Report.
    Mueller PA; Kojima Y; Huynh KT; Maldonado RA; Ye J; Tavori H; Pamir N; Leeper NJ; Fazio S
    Arterioscler Thromb Vasc Biol; 2022 Jan; 42(1):e1-e9. PubMed ID: 34758632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Jnk1 Deficiency in Hematopoietic Cells Suppresses Macrophage Apoptosis and Increases Atherosclerosis in Low-Density Lipoprotein Receptor Null Mice.
    Babaev VR; Yeung M; Erbay E; Ding L; Zhang Y; May JM; Fazio S; Hotamisligil GS; Linton MF
    Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1122-31. PubMed ID: 27102962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted invalidation of SR-B1 in macrophages reduces macrophage apoptosis and accelerates atherosclerosis.
    Galle-Treger L; Moreau M; Ballaire R; Poupel L; Huby T; Sasso E; Troise F; Poti F; Lesnik P; Le Goff W; Gautier EL; Huby T
    Cardiovasc Res; 2020 Mar; 116(3):554-565. PubMed ID: 31119270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ERV1/ChemR23 Signaling Protects Against Atherosclerosis by Modifying Oxidized Low-Density Lipoprotein Uptake and Phagocytosis in Macrophages.
    Laguna-Fernandez A; Checa A; Carracedo M; Artiach G; Petri MH; Baumgartner R; Forteza MJ; Jiang X; Andonova T; Walker ME; Dalli J; Arnardottir H; Gisterå A; Thul S; Wheelock CE; Paulsson-Berne G; Ketelhuth DFJ; Hansson GK; Bäck M
    Circulation; 2018 Oct; 138(16):1693-1705. PubMed ID: 29739755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-Like Growth Factor-1 Receptor Deficiency in Macrophages Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Apolipoprotein E-Deficient Mice.
    Higashi Y; Sukhanov S; Shai SY; Danchuk S; Tang R; Snarski P; Li Z; Lobelle-Rich P; Wang M; Wang D; Yu H; Korthuis R; Delafontaine P
    Circulation; 2016 Jun; 133(23):2263-78. PubMed ID: 27154724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P2Y6 deficiency limits vascular inflammation and atherosclerosis in mice.
    Stachon P; Peikert A; Michel NA; Hergeth S; Marchini T; Wolf D; Dufner B; Hoppe N; Ayata CK; Grimm M; Cicko S; Schulte L; Reinöhl J; von zur Muhlen C; Bode C; Idzko M; Zirlik A
    Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2237-45. PubMed ID: 25104800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limited Macrophage Positional Dynamics in Progressing or Regressing Murine Atherosclerotic Plaques-Brief Report.
    Williams JW; Martel C; Potteaux S; Esaulova E; Ingersoll MA; Elvington A; Saunders BT; Huang LH; Habenicht AJ; Zinselmeyer BH; Randolph GJ
    Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1702-1710. PubMed ID: 29903736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-205-5p Promotes Unstable Atherosclerotic Plaque Formation In Vivo.
    Meng X; Yin J; Yu X; Guo Y
    Cardiovasc Drugs Ther; 2020 Feb; 34(1):25-39. PubMed ID: 32034643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein E-/- Mice Lacking Hemopexin Develop Increased Atherosclerosis via Mechanisms That Include Oxidative Stress and Altered Macrophage Function.
    Mehta NU; Grijalva V; Hama S; Wagner A; Navab M; Fogelman AM; Reddy ST
    Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1152-63. PubMed ID: 27079878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haloperidol inhibits the development of atherosclerotic lesions in LDL receptor knockout mice.
    van der Sluis RJ; Nahon JE; Reuwer AQ; Van Eck M; Hoekstra M
    Br J Pharmacol; 2015 May; 172(9):2397-405. PubMed ID: 25572138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of myeloid Fatp1 increases atherosclerotic lesion size in Ldlr
    Zhao L; Cozzo AJ; Johnson AR; Christensen T; Freemerman AJ; Bear JE; Rotty JD; Bennett BJ; Makowski L
    Atherosclerosis; 2017 Nov; 266():182-189. PubMed ID: 29035781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic Deletion of IL-19 (Interleukin-19) Exacerbates Atherogenesis in
    Ray M; Gabunia K; Vrakas CN; Herman AB; Kako F; Kelemen SE; Grisanti LA; Autieri MV
    Arterioscler Thromb Vasc Biol; 2018 Jun; 38(6):1297-1308. PubMed ID: 29674474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progranulin in the hematopoietic compartment protects mice from atherosclerosis.
    Nguyen AD; Nguyen TA; Singh RK; Eberlé D; Zhang J; Abate JP; Robles A; Koliwad S; Huang EJ; Maxfield FR; Walther TC; Farese RV
    Atherosclerosis; 2018 Oct; 277():145-154. PubMed ID: 30212683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mediator 1 Is Atherosclerosis Protective by Regulating Macrophage Polarization.
    Bai L; Li Z; Li Q; Guan H; Zhao S; Liu R; Wang R; Zhang J; Jia Y; Fan J; Wang N; Reddy JK; Shyy JY; Liu E
    Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1470-1481. PubMed ID: 28642237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Palmitoylethanolamide Promotes a Proresolving Macrophage Phenotype and Attenuates Atherosclerotic Plaque Formation.
    Rinne P; Guillamat-Prats R; Rami M; Bindila L; Ring L; Lyytikäinen LP; Raitoharju E; Oksala N; Lehtimäki T; Weber C; van der Vorst EPC; Steffens S
    Arterioscler Thromb Vasc Biol; 2018 Nov; 38(11):2562-2575. PubMed ID: 30354245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloid β-Catenin Deficiency Exacerbates Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice.
    Wang F; Liu Z; Park SH; Gwag T; Lu W; Ma M; Sui Y; Zhou C
    Arterioscler Thromb Vasc Biol; 2018 Jul; 38(7):1468-1478. PubMed ID: 29724817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.